Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Furin Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB15032
This item is not returnable.
View return policy
Description
Furin Monoclonal specifically detects Furin in Human samples. It is validated for Western Blot, ELISA Capture (Matched Antibody Pair).Specifications
Furin | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL | |
NP_002560 | |
FURIN | |
Mouse myeloma cell line NS0-derived recombinant human Furin Asp108-Glu715 Accession # NP_002560 | |
500 μg | |
Primary | |
Detects human Furin in ELISAs and Western blots. | |
Human | |
Purified |
Western Blot, ELISA | |
222712 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
Dibasic-processing enzyme, EC 3.4.21, EC 3.4.21.75, FUR, FURdibasic processing enzyme, furin (paired basic amino acid cleaving enzyme), furin, membrane associated receptor protein, PACE, PACEFES upstream region, paired basic amino acid cleaving enzyme (furin, membrane associated receptorprotein), Paired basic amino acid residue-cleaving enzyme, PC, PCSK3, PCSK3furin, proprotein convertase subtilisin/kexin type 3, SPC1 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
5045 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction